Clinical Trial Update: To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) . [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports completion of the study evaluating HSK31679 for efficacy and safety in Chinese patients with non-alcoholic steatohepatit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Steatohepatitis

Drugs mentioned

• HSK31679 (HSK31679)

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Non-Alcoholic Steatohepatitis (NASH) | Phase 2 | Status: COMPLETED